Artificial Intelligence | Machine Learning | Natural Language Processing OncoHost | A New Dimension to Cancer Care


Enterprise, Pharmaceuticals, Biotechnology, Healthcare, Cancer Therapy Binyamina, Hefa, Israel

OncoHost

Artificial Intelligence | Machine Learning | Natural Language Processing


OncoHost | A New Dimension to Cancer Care

OncoHost

Pharmaceuticals, Biotechnology, Healthcare, Cancer Therapy


Binyamina, Hefa, Israel

OncoHost develops personalized strategies to maximize the success of cancer therapy. Utilizing proprietary proteomic analysis, we aim to understand the patient's unique response to therapy and overcome one of the major obstacles in clinical oncology today – resistance to therapy. Based on robust scientific infrastructure and a strong IP position, OncoHost is launching an extensive clinical program with leading academic and clinical partners.

OncoHost's platform analyzes proteomic changes in blood samples to monitor the dynamics of biological processes induced by the patient in response to given cancer therapy. Response Profiling also identifies potential drug targets, advancing the development of novel therapeutic strategies.OncoHost's profiling platform offers a new layer of information, enabling early identification of non-responsiveness to cancer treatments and the discovery of new targets to overcome treatment resistance.

 

B2B

1 to 25

Series B

$16 M

Scaling Up

2017

 
 

Pharmaceuticals
Healthcare
Health Care Facilities & Hospitals
Biotechnology

Improves Clinical Trial Success Rate
Improved Outcomes & Reduced Side Effects

Increase Efficiency

 
 

N/A

Yes

Active

 
 

   Machine Learning
   Natural Language Processing
   Automated Planning and Search


Health Care

Health Care

Biotechnology

Biotechnology

Cancer Therapy

Cancer Therapy


Image

Image

Video

Video

Audio

Audio

Text

Text

Structured

Structured

 

   Software


N/A


Machine Learning Algorithm

Machine Learning Algorithm

Cancer Diagnosis Algorithm

Cancer Diagnosis Algorithm

Deep Learning Algorithm

Deep Learning Algorithm

 
 

Dec 2021

  • OncoHost Collaborates with Lung Biobank Heidelberg
 
 

4

1

$35M

Company was founded 2017 and it took almost 5 years (May 2022) to raise first external round

 
 

Date

Round

$ Raised

Investors

05/10/2022

Series C

$35M

ALIVE Israel HealthTech Fund, Leumi Partners, Menora Mivtachim, OurCrowd

Date : 05/10/2022

Round: Series C

$ Raised: $35M

Investors: ALIVE Israel HealthTech Fund, Leumi Partners, Menora Mivtachim, OurCrowd

 

Investors

Interested in researching OncoHost?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about OncoHost

Request a Demo - Deal Souring Platform

 
Ofer Sharon


Ofer Sharon
CEO

Moti Hacham


Moti Hacham
Chief Financial Officer

Yehonatan Elon


Yehonatan Elon
Chief Technology Officer

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ OncoHost